A range of treatments exist for heroin and opiate pain pill addiction, including medications and behavioral therapies. Treatment usually begins with medically assisted detox to help patients withdraw from the opiates safely.
Medications such as clonidine and Suboxone (buprenorphine) can be used to help minimize symptoms of withdrawal. However, detox alone is NOT treatment and has NOT been shown to be effective in preventing relapse – it is just the first step.
INSynergy can assist with a painless detox from heroin addiction and opiate pain pills. Once detoxed, INSynergy can offer new options for blocking the effects of heroin and opiate pain pills and preventing relapse with new FDA approved medications designed for the treatment of heroin and opiate pain pill addictions.
Vivitrol and Suboxone – two new medical breakthroughs for the treatment of heroin and opiate addiction now available at INSynergy!
VIVITROL is the first and only non-addictive drug approved by the US Food and Drug Administration to prevent opioid dependence after patients have gone through opioid detoxification. Vivitrol is an injectable time released form of naltrexone that is taken once a month. Vivitrol acts on the brain’s receptors for pleasure, blocking the receptor’s ability to gain any reaction from chemicals such as heroin or opiate pain pills.
When opioids like heroin or pain pills are in your body, they send signals to the brain’s reward system, creating a euphoric feeling that can lead to addiction. VIVITROL blocks these signals.
VIVITROL blocks the effects of opiates and prevents dependence.
The BRIDGE is an FDA cleared device used to treat acute or chronic pain. As a tool, The Bridge can help with one of the most challenging aspects of overcoming an opioid addiction – the pain during the initial detox
INSynergy has also pioneered the use of The Bridge Device to treat pain during the period of opiate/heroin withdrawals. The Bridge is FDA cleared to be used in acute or chronic pain. It interferes with pain signals from the spine and brain and is easy to install in the office. The INSynergy-Bridge protocol is a patent-pending process that uses The Bridge Device as a tool to comfortably transition to Vivitrol, a monthly injection of naltrexone, which is non-addicting and non-divertable.